Nabriva Therapeutics plc
NBRV
|
|
| |
|
| Trading Volume | 717,233 |
|
|
0.00 - 0.00 |
| Market Cap Full | $ 4.6M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | - | - | -6% | -29.9% |
| Q2 | - | - | -13.3% | -56.7% |
| Q3 | - | - | -5.3% | 1042.9% |
| Q4 | - | - | - | -11.5% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2023 | |||||||||||
| -13.6 | 9.4 | -0.6 | -6.9 | -3.7 | -3.2 | -5.3 | - | - | - | - | - |
| 2022 | |||||||||||
| -19.4 | -6 | -7.5 | -25.5 | -33.9 | -12.1 | -2.2 | -8.4 | 1176.1 | 22.1 | -11.4 | -18.2 |
| 2021 | |||||||||||
| 7.4 | -12.2 | -27.8 | 7.2 | -22.5 | -2.2 | -18.9 | -3.2 | 12.3 | -3.4 | -32.3 | -23.1 |
| 2020 | |||||||||||
| 2.3 | -6.6 | -54.7 | -4.6 | 107.9 | -40.8 | 12.7 | -19.5 | -12.9 | -7.1 | -13.7 | 471.4 |
EPS
| 2022 | 2021 | 2020 | |
|---|---|---|---|
| Q1 | -0.5 | -0.1 | -0.3 |
| Q2 | -0.5 | -0 | -0.1 |
| Q3 | -0.4 | -0 | -0.1 |
| Q4 | 0 | -0.3 | -0.1 |
| A | -21.3 | -28.5 | -135.2 |